World of DTC Marketing
DECEMBER 3, 2021
LEAD-IN: Yesterday I had a long talk with someone who has been in the industry for over 25 years. She has decided to leave the pharma industry because she said, “patients have been reduced to numbers on an excel spreadsheet” and “I am tired of trying to get coworkers to see them as people with real needs.” According to my WordPress stats, I have over 100 readers a day.
Bio Pharma Dive
DECEMBER 3, 2021
Usama Malik, chief financial officer of Immunomedics from 2017 to late 2020, is charged with tipping his partner and several relatives of positive study results for the biotech's breast cancer drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 3, 2021
An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.
Pharma Times
DECEMBER 3, 2021
The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has no previous connection to the previous nine.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
DECEMBER 3, 2021
As Omicron continues to be closely watched around the world with more information awaited from researchers, COVID-19 vaccine makers Pfizer and Moderna announced they’re getting to work on a booster for the newest COVID-19 variant of concern (VOC). While Pfizer said it will have an Omicron-targeting vaccine ready in 100 days, Moderna took it a step further saying that a variant booster is needed because the current COVID-19 vaccines probably won’t work well against it.
Scienmag
DECEMBER 3, 2021
A multi-institutional team of astrophysicists headquartered at Boston University, led by BU astrophysicist Merav Opher, has made a breakthrough discovery in our understanding of the cosmic forces that shape the protective bubble surrounding our solar system—a bubble that shelters life on Earth and is known by space researchers as the heliosphere. Credit: Merav Opher, et. […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 3, 2021
Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track to expand the eligible patient population for the drug thanks to new phase 3 data. Just released results from the ARASENS trial show that adding Nubeqa (darolutamide) to docetaxel chemotherapy and androgen deprivation therapy (ADT) to switch off testosterone production helps men with castration-sensitive prostate cancer (CSPC).
Scienmag
DECEMBER 3, 2021
The Department of Defense (DOD) has awarded a $1.5 million grant to a research team in The University of Texas at Arlington’s Aerodynamics Research Center to examine how lasers could be utilized to destroy hypersonic threats to the United States. Credit: UT Arlington The Department of Defense (DOD) has awarded a $1.5 million grant to […].
ECRG Media's Clinical Research Podcast
DECEMBER 3, 2021
Senior CRA Gives Words Of Advice to New Clinical Researchers Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group or ECRG for short
Scienmag
DECEMBER 3, 2021
East Hanover, NJ. December 3, 2021. A pilot study by a team of multiple sclerosis (MS) researchers showed that treadmill walking exercise training may be an effective approach to managing the debilitating cognitive effects of the disease. Their article, titled, “Effects of walking exercise training on learning and memory and hippocampal neuroimaging outcomes in MS: […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
ECRG Media's Clinical Research Podcast
DECEMBER 3, 2021
Senior CRA Gives Words Of Advice to New Clinical Researchers. Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Scienmag
DECEMBER 3, 2021
Compare with bulk graphitic carbon nitride, the optimal sample had 2.93-fold photocatalytic nitrate reduction to ammonia activity (2.627?mg/h/gcat), and the NH3 selectivity increased from 50.77% to 77.9%. They published their approach on September 06 in the Energy Material Advances. Credit: An Feng, University of Technology Sydney Compare with bulk graphitic carbon nitride, the optimal sample […].
The Pharma Data
DECEMBER 3, 2021
In the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course received only one two-week course of treatment during the study and nearly 80% received only one or two treatment courses in total. Zuranolone 50 mg was generally well-tolerated with an overall adverse event profile consistent with data reported earlier and 6.5% of patients discontinuing study drug due to adverse events.
Scienmag
DECEMBER 3, 2021
WASHINGTON, December 3, 2021 — Food texture can make the difference between passing on a plate and love at first bite. To date, most studies on food texture center on relating a food’s overall composition to its mechanical properties. Our understanding of how microscopic structure and changes in the shape of food affect food texture, […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Intouch Solutions
DECEMBER 3, 2021
Women in STEM & Healthcare (WISH) at Intouch is a women’s leadership network created by two marketing coordinators — Anan Vijay and Anna Mandarino — to facilitate communication, support, and the flow of resources between Intouch’s various departments and affiliates. The initiative was designed under the guidance of the Inclusion + Diversity with the help of director of inclusion Antonio Rivera and inclusion, and diversity manager Adrienne Bradford to continue to champion di
Scienmag
DECEMBER 3, 2021
What are the effects of eating during the nighttime instead of the daytime? New research, focused on a simulation of night shift work, may hold implications for people eating at atypical times — like those experiencing jet lag, circadian rhythm sleep disorders, or who tend to sleep late during the weekends. A study by investigators […].
pharmaphorum
DECEMBER 3, 2021
More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community. From calls for more diversity in age, gender, and ethnic groups, to more consideration for lifestyle and cultural differences, trials need to ensure they represent the key population of interest and identify a greater range of opportunities to maximise benefits for both patients and pharma.
Scienmag
DECEMBER 3, 2021
An interdisciplinary team of researchers from the Georgia Institute of Technology has received a $2 million federal grant to create tools that will provide the clearest three-dimensional images yet of the chemical and biomolecular interactions between plants and the soil in which they grow. Credit: Chad Ralston An interdisciplinary team of researchers from the Georgia […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
DECEMBER 3, 2021
The seismic shift away from face-to-face meetings caused by the pandemic has given the pharmaceutical industry a fundamental challenge around engaging with clinical staff. Sales representatives are finding it difficult to chisel out any personal time from doctors whose diaries are dominated by virtual connections. Every moment in front of a clinician is prized so when you get past the virtual draw-bridge, you better be prepared is the mantra emerging from sales experts.
Scienmag
DECEMBER 3, 2021
Credit: Space?Science & Technology Robots are already in space. From landers on the moon to rovers on Mars and more, robots are the perfect candidates for space exploration: they can bear extreme environments while consistently repeating the same tasks in exactly the same way without tiring. Like robots on Earth, they can accomplish both dangerous […].
XTalks
DECEMBER 3, 2021
Spoiler Alert , a Boston-based software company that helps perishable consumer packaged goods (CPG) brands manage excess inventory, announced on Wednesday that it raised $11 million in a series A funding round. The backing follows the rapid implementation of the company’s software over the last year, during which the company experienced over 400 percent growth in gross transaction value. .
Scienmag
DECEMBER 3, 2021
A team of researchers from the Georgia Institute of Technology has developed an analytical tool designed to improve the biomanufacturing process of advanced cell-based therapies. Credit: Austin Culberson A team of researchers from the Georgia Institute of Technology has developed an analytical tool designed to improve the biomanufacturing process of advanced cell-based therapies.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
NY Times
DECEMBER 3, 2021
Vaccine shortages and skepticism, and rewarding countries for discovering variants. Also: Happiness and politics; unwanted children; beware of psychedelics.
Scienmag
DECEMBER 3, 2021
– The December issues of two of the American Psychiatric Association journals, The American Journal of Psychiatry and Psychiatric Services are available online. The American Journal of Psychiatry is the most widely read psychiatric journal in the world. The December issue is dedicated to “New Insights into Major Depression and the Treatment of Bipolar Depression,” […].
Drug Discovery Today
DECEMBER 3, 2021
Alderley Park, Cheshire – One of the UK’s leading infectious disease biotech companies has announced a breakthrough in laboratory trials of a new drug to treat COVID-19 and new variants of the disease, such as the Omicron variant.
Scienmag
DECEMBER 3, 2021
Embargoed: Not for Release Until 2:00 pm U.S. Eastern Time Friday, 03 December Credit: York University Embargoed: Not for Release Until 2:00 pm U.S. Eastern Time Friday, 03 December TORONTO, Dec. 3, 2021 – For decades, scientists have hotly debated the origin of the western honey bee. Now, new research led by York University has […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioTech 365
DECEMBER 3, 2021
P3 Health Partners Closes Business Combination with Foresight Acquisition Corp. and Will Begin Trading on the Nasdaq P3 Health Partners Closes Business Combination with Foresight Acquisition Corp.
Scienmag
DECEMBER 3, 2021
Ocean pollution is unfortunately becoming more commonplace, raising concerns over the effect of chemicals that are leaching into the water. In a new study, researchers have discovered how these chemicals can affect the reproduction in common anemonefish Amphiprion ocellaris. Credit: Ed Clint Ocean pollution is unfortunately becoming more commonplace, raising concerns over the effect of chemicals […].
BioTech 365
DECEMBER 3, 2021
Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec.
Scienmag
DECEMBER 3, 2021
AMES, IA – Business leaders and management experts often encourage people to speak up in the workplace. Suggesting a creative idea or a more efficient way to work can help companies overcome challenges and meet goals. But new research shows another, more subtle and often overlooked form of speaking up has a big effect on […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
259 
Let's personalize your content